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Abstract.  A  COOH-terminal double lysine motif 
maintains  type I transmembrane proteins in the ER. 
Proteins tagged with this motif, eg.,  CD8/E19 and 
CD4/E19,  rapidly receive post-translational  modifica- 
tions characteristic  of the intermediate compartment 
and partially colocalized to this organdie.  These pro- 
teins also received modifications characteristic  of the 
Golgi but much more slowly. Lectin staining  localized 
these Golgi modified proteins to ER indicating that 
this motif is a retrieval signal.  Differences in the sub- 
cellular distribution and rate of post-translational 
modification of CD8 maintained in the ER by se- 
quences derived from a variety of ER resident proteins 
suggested that the efficiency of retrieval was dependent 
on the sequence context of the double lysine motif and 
that retrieval may be initiated from multiple positions 
along the exocytotic pathway. 
S 
OME proteins remain in the ER as permanent residents, 
whereas others are exported to the Golgi  stack for 
subsequent distribution  to the cell surface, lysosomes, 
secretory vesicles, et cetera. Current opinion favors the idea 
that transport of proteins between the organdies occurs by 
default (Wieland et al.,  1987; Pfeffer and Rothman,  1987). 
Consequently,  residency in the ER requires mechanisms that 
recognize and maintain  the proteins in that location.  A rec- 
ognition  motif for the retention  of soluble ER proteins,  the 
COOH-terminal sequence Lys-Asp-Glu-Leu  (KDEL),' has 
been identified (Munroe and Pelham,  1987; Pelham,  1989). 
Likewise, some ER resident type I transmembrane proteins 
contain an ER targeting motif (Nilsson et al., 1989) consist- 
ing of two lysine residues at the -3 and either the -4 or -5 
position from the COOH terminus  (Jackson  et al.,  1990). 
ER retention may involve two principally different mecha- 
nisms.  Either proteins are retained by being excluded from 
transport vesicles or they enter such vesicles to be subse- 
quently retrieved  to the ER. Two putative receptors recog- 
nizing the KDEL motif have been described (Lewis and Pel- 
ham,  1990; Vaux et al., 1990). Their locations in the Golgi 
and intermediate  compartmentlike structures,  respectively 
(Lewis and Pelham,  1990, 1992; Vaux et al.,  1990),  argue 
for retrieval being the mechanism  by which KDEL proteins 
become resident of the ER (see Pelham,  1989; Lewis and 
Pelham,  1992).  Thus,  the  putative  KDEL  receptor  may 
recirculate between the ER and the post-ER compartments 
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(Lewis and Pelham,  1992) as has been shown by morpholog- 
ical analyses  for some marker proteins in the intermediate 
compartment (Lippincott-Schwartz  et al,,  1989; Schweizer 
et al.,  1990;  Saraste  and Svensson,  1991) and for class I 
MHC  molecules  (Hsu  et  al.,  1991). The  existence  of a 
microtubule-dependent retrograde pathway has also been un- 
covered  by  treating  cells  with  brefeldin  A  (Lippincott- 
Schwartz  et al.,  1990) although  some reservations  remain 
about its physiological  significance. 
Studies on the retrieval of  proteins to the ER or their reten- 
tion in this or other organelles has been hampered by the lack 
of biochemical markers  permitting  kinetic  studies.  Thus, 
morphological  analyses can only reveal accumulation  of  pro- 
teins as a consequence of a rate limiting step in the transport 
pathway. For this  reason,  it is not fully understood from 
which organdies proteins can be retrieved to the ER, nor is 
it clear what the requirements  for retrieval  are. 
To address the mechanism by which transmembrane pro- 
teins with the double-lysine motif are maintained  in the ER, 
we have examined  the post-translational  modifications  and 
the subcellular distribution  of marker proteins onto which a 
double lysine motif has been engineered.  We now report that 
such proteins partially localize to the intermediate  compart- 
ment and provide both biochemical and morphological  evi- 
dence that  they are retrieved  to the ER from this  and the 
Golgi compartments. 
Materials and Methods 
Recombinant DNA 
Construction of the expression plasmids encoding CD8/E19, CD8/E19-3S, 
CDS/H25,  CDg/HPI,  CDS/53kSER,  CDS/HMGCoA,  CD4/EI9,  CIM/ 
H25, CD4/HP1,  CD4/53kSER and CD4/HMGCoA have been previously 
described (Nflsson  et al.,  1989;  Jackson et al.,  1990).  Construction of 
CDSsol and CDS/KDEL utilized the PCR and oligonucleotides  with CD8 
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reactions were carried out essentially described previously (Nilsson et al., 
1989). A 5' primer  encoding two Barn HI sites followed by nucleotides 
65-82 of the CD8 sequence was used together with a 3' primer encoding 
the complementary sequence to nucleotides 584-602  in the CD8 sequence 
followed by a stop codon TGA and two BamHI sites in the PCR to pro- 
duce the CD8sol eDNA. The COOH terminus of the encoded eDNA was 
-AVHTRGLDFA. The same 5' primer was used with a 3' primer encoding 
the complementary sequence to nucleotides 584-602  in the CD8 sequence 
followed  by  the  sequence  AGTGAAAAAGATGAGTTGTGAGGATCC- 
GGATCC, the COOH terminus of the encoded protein CD8/KDEL  was 
-AVHTRGLDFASEKDEL. CD8/E19-C/S was constructed using oligonu- 
cleotide cassettes, an oligonucleotide coding for nucleotides 606-646 fol- 
lowed by a KpnI site and an Xba I site was annealed with a complementary 
oligonuclootide  and  cloned  into the CD8/E19  vector  which  had been 
cleaved with Eco RV and Xba I. Oligonucleotides encoding the missing por- 
tion of CD8/EI9 with the codon for amino acid 158 changed from TGC to 
TCC were direetionally cloned into the above plasmid between the Kpn I 
and  XbaI  sites.  The  resulting plasmid encoded  CD8/E19  with  a  single 
amino acid substitution at amino acid 158 of cysteine to serine. 
HLA A2.2 eDNA was obtained from P. Parham (Holmes et al., 1987) 
and used as a template  for a PCR with oligonucleotides that result in a 
recombinant  eDNA  encoding the complete extracelhilar  and transmem- 
brane domains  of A2.2  and  a  cytoplasmic  tail  derived  from El9,  the 
carboxy-terminai sequence of the recombinant A2.2/E19 was -GAWAA- 
VMWKYKSRRSFIDEKKMP. The same 5'primer  was used with a 3'primer 
encoding a SEKDEL tail preceded by sequence from the 3' end of  the alpha 
3 domain, the resulting eDNA encode a soluble A2.2 with a COOH termi- 
nus of-PLTYLRWSEKDEL. 
Rat prealbumin eDNA (Sundelin et al., 1985) was used as a template in 
a PCR reaction to produce a recombinant eDNA encoded a preaibumin pro- 
tein  with  the amino  acid  sequence  SEKDEL  at  the COOH  terminus, 
(Melhus, 1990). All of the above recombinant eDNAs were sequenced and 
cloned into the expression vector pCMU (Nilsson et al., 1989) for transient 
expression in mammalian ceils or into pBS +  (Stratagene Inc., La Jolla, 
CA) for production of mRNA using "1"7 polymerase for use in an in vitro 
translation kit (Promaga Corp., Madison, WI). 
Cell Culture and Transfection 
HeLa and NIH 3"1"3 cells were grown in DME supplemented with 8% FCS, 
2 mM glutamine,  100 U/ml penicillin and streptomycin at 100/~g/ml. For 
the temperature  shift experiments, this media was supplemented with 10 
mM Hepes buffer pH 7.3. Transfections were carried out using the calcium 
phosphate method as described previously (Nilsson et ai.,  1989), except 
that 25 #g of DNA were used to transfect 1 ×  10  s cells in a 100-ram petri 
dish. 
Metabolic Labeling,  lmmunoprecipitation, Endo H 
and Neuraminadase Treatment 
Metabolic  labeling  of cells  was carried  out as  follows, 60-72  h  post- 
transfection, cells were rinsed in PBS three times and then incubated for 
20 rain in methionine deficient DME (Gibco/BRL, Gaithersburg, MD) be- 
fore addition of the pulse media.  Pulse media contained 0.2 mCi/ml  of 
[35S]methionine  (Trans-label; ICN Biochemicals Inc., Costa Mesa, CA) in 
methionine deficient DME. Cells were labeled and subsequently chased in 
the presence of culture media for the times indicated in the individual ex- 
periments. Immediately after the chase period cells were rinsed in PBS and 
lysed in situ with 1% Triton X-100/PBS. Lysates were precleared by cen- 
trifugation in a microfuge for 2  ×  15 rain to remove cell debris, followed 
by a 2-h incubation with protein A Sepharose (Pharmacia LKB Biotechnol- 
ogy, Inc., Piscataway, NJ). The Scpharose was then removed by centrifuga- 
tion and antibody was added to the lysate. After 2 h, protein A Scpharose 
was incubated with the lysate for 30 rain, and subsequently collected by cen- 
trifugation. The Scpharose beads were washed 5 times in PBS containing 
0.1% Triton X-100 before analysis by SDS PAGE. Samples were treated for 
digestion with Endo H (endoglycosidase H, Boehringer Mannheim Corp., 
Indianapolis, IN) or neuraminiadase (Calbiochem Corp., La Jolla, CA) as 
described by the manufacturers. Preparation of semi-intact cells was as pre- 
viously described (Beckers et ai., 1987) except that ceils were scraped off 
the dish immediately after labeling without osmotic swelling, this resulted 
in >90%  of the cells becoming permeable to trypan blue. The semi-intact 
cell preparations were used in the standard ER to Golgi in vitro transport 
assay described by Beckers et al. (1987) in the presence or absence of 150 
/tM UDP-GaiNAc (Sigma Chemical Co., St. Louis, MO). Labeling with 
[3H]palmitic acid  (Amersham Corp., Arlington Heights, IL) was as de- 
scribed by Buss and Scfton (1986). 10-15% aerylamide gradient gels were 
used for the analysis of CD8 chimeras, 10% gels were used for the analysis 
of CD4 and HLA A2 chimeras. After electrophoresis, gels were fixed and 
treated with Amplify (Amersham Corp.).  Radioactive protein marker pro- 
teins: BSA (67 kD), ovalbumin (46 kD), carbonic anhydrase (30 kD) and 
lactoglobulin A (18.4 kD) were obtained from New England Nuclear (Bos- 
ton, MA). 
Nocodazole and Brefeldin A Treatment of Cells 
To depolimerize microtubules, cells were incubated in ice cold media for 
25 min, the media was then replaced with 37°C DME for the control ceils, 
or with DME containing 10 #g/ml nocodazole (Aldrich Chemical Co., Mil- 
waukee, WI),  after 1 h  in this media  cells were prepared  for labeling, 
nocadozole was maintained in the prelabeling, labeling and chase media. 
We determined by immunofluorescence microscopy with antitubulin anti- 
bodies (Boehringer Mannheim,  Corp.)  that immediately before labeling, 
the above pre-treatments left an intact microtubule network in the control 
cells, while no detectable microtubules could be identified in the nocoda- 
zole treated cells. Brefeldin A (Epicentre Technologies) treatment (2 #g/ml) 
was for 1 h before labeling; the drug was maintained in the media through 
out the experiment. 
Subcellular Fractionation 
Subcellular fractionation was carried out as previously described (Bole et 
al., 1986). Briefly, 5 x  107 HeLa cells transfected with CDS/EI9 were bio- 
synthetically labeled for 2 h with [35S]translabel as described above and 
chased for 24 h in the presence of  unlabeled methionine. After washing and 
homogenization the postnuclear supernatant was centrifuged (40,000 rpm 
for 2 h in a Beckman SW41 rotor) through a discontinuous sucrose gradient. 
19 fractions were collected from the gradient, these were analyzed for the 
presence of galactosyltransferase activity (see Hsu et ai., 1991). Anti-CD8 
and anti-epoxide hydrolase antibodies were added to each fraction along the 
Triton X-100 (1%). Immunoprecipitates were analyzed on SDS PAGE and 
the levels of radioactivity in individual bands qnantitated using an Ambis 
radioanaiytic imaging system. 
Antibodies 
Ascites fluid containing monoclonal antibodies against CD8 (OKTS) and 
HLA A2.2 (BW/.2) were prepared by using hybridoma No. CRL 8014 and 
HB82 from ATCC. Ascites fluid from 19Thy/5D7 a monoclonal antibody 
against human CD4 was kindly provided by E. Rainlaerz. Rabbit antisera 
against: the p58 marker protein of the intermediate compartment (Saraste 
et al., 1987) were provided by J. Saraste (Ludwig Institute for Cancer Re- 
search,  Stockholm, Sweden), epoxide hydrolase (Bnlleid et al.,  1986) by 
J. Craft  (University of Glasgow, Glasgow, Scotland), UDP-ghcuronosyl- 
transferase  (scragg et al.,  1985) by B. Burchell (University of Dundee, 
Scotland), a 135-kD Golgi protein (mAb 53FC3, Burke et al., 1982) by B. 
Burke (Harvard Medical School, Boston, MA), and against BiP (Vanx et 
al., 1990) by S. Fuller (European Molecular Biology Laboratories, Heidel- 
berg, Germany). Antibodies against HPA and PNA lectins were obtained 
from Bioproducts for Science (Indianapolis, IN). Fluorescein and Texas red 
labeled affinity purified Goat anti-rabbit or mouse IgG were obtained from 
Cappell Laboratories  (Malveru, PA) and Molecular Probes Inc. (Eugene, 
OR). Biotinylated antibodies to CD8 and CIM, and Texas red and fluores- 
cein labeled strepavidin were obtained from Becton Dickinson lmmuno- 
cytometry Systems (Mountain View, CA). 
lmmunofluorescence Microscopy 
Ceils were fixed and stained for immunofluoresence as described previously 
(Jackson et al., 1990). Nocodazole and brefeldin A treatment of cells was 
as described for the pretreatment in the pulse chase experiments above. To 
stain with the anti-lectin antibodies ceils were pre-incubated in PBS con- 
taming the appropriate lectin (Sigma Chemical Co.) at a concentration of 
25 #g/ml for 30 rain. Blocking of surface PNA binding was carried out by 
a 30-min pre-incubation with 50 #g/ml Bauhinia purpurea agglutinin. Pri- 
mary antibodies were typically used at a dilution of 1:200 in PBS containing 
0.2% gelatin. To be able to double stain cells where both antibodies were 
of murine origin, standard staining was carried out with one antibody, the 
cells were then incubated in the presence  of  an excess of  pre-immune mouse 
IgG with the second antibody which had been conjugated to biotin. Binding 
of the biotinylated antibody was then detected with streptavidin coupled to 
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performed using a Zeiss axiophot microscope using a 63X objective. Kodak 
ektachrome 400 film was used for photography. Confocal microscopy was 
performed on a BioRad MRC-600. 
Results 
Construction of  ER Retained Transmembrane 
and Soluble Forms of  CD8 
Our  primary  aim  was  to  determine whether the double- 
lysine ER targeting motif acted by simply retaining (fixing) 
proteins in the ER or by retrieving proteins from post ER 
compartments, as suggested for the KDEL motif (Pelham, 
1989).  For  this  reason  we  have  compared  the  post- 
translational modifications of essentially the same marker 
protein, CD8, maintained in the ER by either a KDEL or a 
double-lysine motif. CD8 was chosen for these studies as it 
receives O-linked carbohydrates, In contrast to the process- 
ing of N-linked carbohydrates, which are difficult  to monitor 
until a protein reaches the medial Golgi (Kornfeld and Korn- 
reid,  1985),  much of the biosynthesis of O-linked sugars 
takes place before the medial Golgi (Piller et al., 1989) and 
addition  of GalNAc,  the  primary  O-glycosylation event, 
most  likely  occurs  in  the  intermediate compartment/cis 
Golgi (Tooze et al., 1988; Deschuyteneer et al., 1988; Roth, 
1984). 
Construction of a CD8 chimera maintained in the ER by 
the  cytoplasmic  tail  of  the  adenoviral  E3/19K  protein, 
CDS/E19, and a mutated derivative, CDS/E19-3S,  where the 
ER targeting motif has been destroyed by replacing one of 
the essential lysines with serine, have been previously de- 
scribed (Nilsson et al.,  1989; Jackson et al., 1990).  cDNAs 
encoding soluble CD8 (CD8sol) and a KDEL tagged deriva- 
tive (CD8/KDEL) were constructed using oligonucleotides 
to introduce a stop codon, or a stop codon preceded by the 
amino acid sequence SEKDEL into the CD8 cDNA at the 
junction between the extracellular and transmembrane do- 
mains.  Expression of these recombinant cDNAs in HeLa 
cells followed by pulse chase analysis (Fig. 1 A) showed that 
after 30 rain of labeling, CD8 sol and CD8/KDEL migrated 
with approximately their predicted electrophoretic mobili- 
ties, although some heterogeneity in their M~ was observed 
(see below). After 2 h of chase, a significant proportion of 
the  CD8sol  migrated  very  much  more  slowly  than  the 
CD8/KDEL, this species was also present in the medium but 
only of the CD8sol cultures. Neuraminadase treatment (not 
shown) indicated that the reduced migration of CD8sol was 
primarily the result of sialic acid addition confirming that af- 
ter 2 h, CD8sol but not CD8/KDEL, had passed through the 
Golgi complex.  These  results were  entirely analogous to 
those previously obtained for the ER maintained transmem- 
brane protein CD8/E19 and its cell surface expressed counter- 
part CD8/E19-3S (Jackson et al., 1990;  see also Fig. 1 C). 
Post-translational Modifications of  CD8/E19 
Pulse chase analysis of  CD8/E19 showed (Fig. 1 B) that, like 
CD8/KDEL, it gradually received post-translational modi- 
fication(s). As wild-type CD8 is O-glycosylated  we have pre- 
viously suggested that these modifications may be the addi- 
tion of multiple GalNAc moieties (Jackson et al.,  1990). 
However, immediately after a short labeling (see Fig.  1 B, 
0 time point, semi-intact cells) CD8/E19 migrated on SDS 
PAGE as predominantly two bands, in contrast to a single 
band for CD8/KDEL. Nascent CD8/E19, determined by trans- 
lating CDS/E19 in a rabbit reticulocyte lysate in the presence 
of dog pancreas microsomes, co-migrated with the slower of 
the two bands (marked with an asterisk in Fig. 1 B, data not 
shown). This suggested that immediately after synthesis, a 
portion of CD8/E19 receives a modification which causes it 
to migrate more rapidly (species marked with a triangle) on 
SDS PAGE.  The series of CD8/E19 species observed after 
labeling (Fig. 1 B, see Fig. 6 A) might then be accounted for 
by the simultaneous existence of molecules containing 0,  1 
and more GalNAc residues. Each form differing in carbo- 
hydrate content showed further heterogeneity as not all mole- 
cules contained the modification which results in more rapid 
migration on SDS-PAGE. 
To examine the contribution of GalNAc addition to the 
post-translational  modification  of  CDS/E19  we  utilized 
semi-intact HeLa cells transfected with CD8/E19 in an in 
vitro ER to Golgi transport assay (Beckers et al.,  1987).  It 
can be seen from Fig.  1 B that if UDP GalNAc was added 
to  the  incubations,  nascent  CD8/E19  rapidly  became 
modified such that after 15 rain it migrated in a manner simi- 
lar to that observed in intact cells. If however,  the incuba- 
tions were not supplemented with UDPGalNAc much less 
modification occurred suggesting that the intracellular pools 
of UDPGalNAc  had been  depleted.  Addition of multiple 
GalNAc moieties to nascent CD8/E19 therefore seems to be 
the  primary  cause  of the  multiple  species  of CD8/E19 
marked by dots in Fig. 1 B, but do not account for the species 
of CD8/E19 marked with a square in Fig. 1 B or the rapidly 
migrating form of CD8/E19 marked with a triangle. 
At early chase times, the post-translational modification  of 
CD8/E19  appeared  to  be  more  extensive  than  that  of 
CD8/KDEL (see Fig.  1, A and B). Such differences might 
be due to palmitylation of CD8/E19,  as a cysteine residue 
(Cys-185)  located at the junction between the transmem- 
brane domain of CD8 and the El9 tail is a potential site for 
such a modification (Schultz et al., 1988).  Oligonucleotides 
were used to mutate this cysteine to a serine residue giving 
rise to the replacement mutant CD8/E19-C/S. Biosynthetic 
pulse  chase  analysis  showed  that just  after labeling,  the 
CD8/E19-C/S migrated as a series of bands which appeared 
to be a subset of those present in CD8/E19 (Fig. I C). Most 
noticeable was the absence in CD8/EI9-C/S of the species 
which migrated more rapidly than nascent CD8/E19.  After 
a chase period of 2 h, CD8/E19 migrated as a triplet, where 
the  slowest  migrating  form  was  the  dominant  species, 
whereas the CD8/E19-C/S consisted of the middle species 
of the three bands seen in CD8/E19.  The dominant species 
observed  for  CD8/E19  (marked  with  a  square)  and 
CD8/E19-C/S at this time point presumably both contain a 
full  complement  of  GalNAc  and  differ  in  their  elec- 
trophoretic properties due to palmitylation of  only CD8/E19. 
Recent studies have shown that palmitylation of proteins 
takes place after exit from the ER (Bonatti et al.,  1989).  It 
was,  thus,  important to demonstrate that cysteine-185  re- 
ceived palmitate.  Fig.  1 C shows  that both CD8/E19 and 
CD8/E19-3S  were readily labeled by overnight incubation 
with [3H]palmitic acid, whereas CD8/E19-C/S did not dis- 
play any labeling. Parallel cultures labeled with [35S]methi- 
onine confirmed that all three proteins were expressed at 
comparable levels (not shown). We propose that soon after 
synthesis, CD8/E19 receives an unknown addition, depen- 
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modifications of  ER maintained 
CD8 chimeras.  (.4) Post-trans- 
lational  modification of CD8- 
sol and CD8/KDEL 72 h post- 
transfection  cells  expressing 
CD8sol and CD8/KDEL were 
labeled  with [35S]-methionine 
for 30 min  and  either  lysed 
immediately  with  1%  Triton 
X-100  or  after  a  2-h  chase 
in  medium  containing  unla- 
beled  methionine.  An  anti- 
CD8  monoclonal  antibody, 
OKT8  was  used to immuno- 
precipitated  CD8 from the ly- 
sates  and  the  medium  from 
the chased cultures.  Fig.  1 A 
shows  an  autoradiograph  of 
the immunoprecipitated CDS- 
sol and CD8IKDEL analyzed 
by SDS PAGE. (B) Addition 
of GalNAc to CD8/E19. HeLa 
ceils  transfected  with  CD8/ 
El9 eDNA were labeled  for 3 
rain with [3sS]methionine, and 
then either analyzed after different chase times (as described in Fig.  1 A) or, washed  with ice cold buffer,  scraped off the dish with a 
rubber policeman, pelleted  by centrifugation  and subsequently  washed twice with ice cold buffer before use in the in vitro transport assay 
as described by Beckers et al.  (1987).  UDPGalNAc (150 tzM) was added to the assay mixture as indicated  in the figure. The assay was 
started by transfer to a 37°C water bath and stopped at the times  indicated  by addition  of 0.5 ml of 1% Triton X-100 in PBS. Fig.  1 B 
shows an autoradiograph of CDS/E19 immtmoprecipitated  from the intact and semi-intact cells,  analyzed by SDS PAGE. The asterisk 
indicates  the migration position of nascent CD8/E19 translated  in a rabbit retienlecyte lysate.  The dots indicate  species  of CD8/E19 that 
have received  GalNAc, and the triangle indicates  the species  of CD8/E19 that migrates more rapidly on SDS due to some unknown 
modification.  (C) Palmitylation of CD8/E19.  HeLa cells transfected  with CDS/E19 or CD8/E19-3S  or CD8/E19C/S eDNA were labeled 
with [3sS]methionine for 30 rain and subsequently  chased in medium containing unlabeled methionine for the times indicated,  or labeled 
overnight in the presence of 3H palmitic acid. CD8 protein was collected by immunoprecipitation and analyzed by SDS PAGE. The asterisk 
and dots on the figure indicate  the migration position of nascent CD8/E19 and GalNAe modified forms of this protein, respectively  (see 
Fig. I B). The asterisk,  dots and triangle indicate the species of CD8/E19 described in Fig.  1 B. The square symbol is positioned adjacent 
to the species  of CD8/E19 which we suggest has a full complement of GaiNAc and palmitate. 
dent upon cysteine 185, which results in a more rapid migra- 
tion of CD8/E19 on SDS PAGE (band marked with a triangle 
in  Fig.  1  C).  As  suggested  above,  the  modifications  of 
cysteine-185 and the carbohydrate addition to CD8 (marked 
by dots), are independent but temporally overlapping events. 
After  ,020  rain  of  chase,  the  unknown  modification  is 
reversed,  perhaps  by  the  addition  of palmitate,  such  that 
electrophoretic  mobility became mainly  dependent  on the 
carbohydrate additions. 
Identification of CD8/E19 and CD4/E19 
in a Post ER Comparlment 
The  above  biochemical  data  in  conjunction  with  other 
reports  (see  Pelham,  1989)  support the idea that proteins 
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localization of CD8/EI9  and 
CD4/E19 to the intermediate 
compartmant/c/s Golgi. Trans- 
fected  31"3 cells  expressing 
CD4/E19 were fixed with 4% 
formaldehyde and  permeabi- 
lized using 0.1% Triton X-IO0. 
Ceils were stained with mouse 
anti-CD4 and rabbit anti-p58 
antibodies (A and B) or mouse 
anti-CD4 and rabbit anti-epox- 
ide  hydrolase  antibodies  (C 
and D). Fluorescein anti-rab- 
bit or Texas  red anti-mouse  sec- 
ondary reagents were used  tO 
identify binding of  the primary 
antibodies. An arrow in Fig. 
2, ,4 and B, indicates a cluster 
of  vesicles that clearly co-stain 
for CIME/19 and p58. (E) Se- 
quences  of  the  cytoplasmic 
tails of the various CD8 and 
CD4 chimeras. The sequences 
shown (see  Jackson  et  al., 
1990) are the complete cyto- 
plasmic tail sequences of the 
chimeras,  based  on the  pre- 
dicted  location of the  trans- 
membrane  domains  of CIM 
(Maddon et al., 1985)  and CD8 
(Littman et al.,  1985). 
with a double-lysine or KDEL-motif  have access to post ER 
compartment(s). However, in contrast to the KDEL recep- 
tors (Lewis and Pelham,  1992; Vaux et al.,  1990), KDEL 
proteins have not been identified in these organelles. 
To determine if proteins  with  the  double-lysine motifs 
localize to post ER compartment(s), transfected 3T3 cells 
were costained for immunofluorescence microscopy utiliz- 
ing antibodies against the tagged marker protein and p58 
(Saraste et al.,  1987).  Immunolocalization has shown that 
p58 is a resident of  the intermediate compartment (Schweizer 
et al.,  1988; Chavrier et al.,  1990), distributed among cis- 
ternae at the cis side of the Golgi apparatus and peripheral 
vesicular structures, that represent the intermediates in ER 
to Golgi transport (Saraste and Kuismenan,  1984; Saraste 
and Svensson, 1991). As the anti-p58 antiserum does not re- 
act with the human homolog, mouse 3T3 cells were used for 
these studies.  Vesicular structures at the periphery of cells 
were identified which costained for CD8/E19 and p58, but 
not for the ER marker proteins, epoxide hydrolase (Galteau 
et al., 1985) or UDP glucuronosyltransferase (Jackson et al., 
1987). However strong ER fluorescence made these results 
difficult to record. Clearer colocalization between p58 and 
an El9 tagged marker protein was obtained with CD4/E19 
(CD4 protein with the entire cytoplasmic tail replaced by 
that  from the adenoviral El9 protein,  see Nilsson et al., 
1989). Costaining vesicles were most apparent when the lev- 
els of protein expression were relatively low,  see arrows in 
Fig. 2, A and B. At higher expression levels strong ER fluo- 
rescence obscured details in the perinuclear region. 
We have previously shown that the ER targeting motif in 
CD8/E19 can be substituted by replacing the last 10 amino 
acids of CD8/E19 with sequences derived from various ER 
resident proteins (See Fig. 2 E). This work allowed us to de- 
termine a common feature of these ER targeting motifs, the 
double  lysine  motif,  and  suggested  that  the  various  se- 
quences were functionally similar  (Jackson et al.,  1990). 
Analysis of these various chimeras produced the surprising 
observation that only CD8/E19 and CD8/HMG CoA dis- 
played  costaining  with  the  p58  vesicles.  The  other  con- 
structs,  CD8/H25,  CD8/HP1  and  CD8/53kSER  showed 
staining similar to the ER marker proteins with no obvious 
concentration in p58 staining vesicles. The common feature 
of the El9 and HMG CoA ER targeting motifs, which distin- 
guishes them from the other three sequences, is that they 
have lysine residues at positions 3 and 4 residues from the 
carboxy terminus (see Fig.  2  E) with no additional basic 
residues among the last 9 amino acids of their tail sequence 
(Jackson et al.,  1990). 
Most interestingly, a  similar phenomenon is observed if 
these  exact  same  cytoplasmic tails  are  present  on  CIM. 
Whereas CIM/E19 and CD4/HMGCoA showed significant 
costaining with p58, CIM/HP1, CIM/H25 and CIM/53kSER 
only partially co-localized with p58 to an extent similar to 
CD8/E19 (data not shown). As morphological analyses show 
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subeellular  localization  of 
CD4/EI9 by temperature. 33"3 
cells transfected with expres- 
sion plasmids encoding CD4/ 
E19 (,4, B, E, and F) or CDS/ 
1-125 (Cand D) were incubated 
at 16"C for 2 h followed by a 
warm-up to 370C for either 
5 rain (A-D)  or 30 min (E-F). 
Cells were fixed  and permeabi- 
lized as in Fig. 2 and co-stained 
using  anti-CD4  antibody  (A 
and E) and anti-p58 antibody 
(B and F) or anti-CD8 anti- 
body (C)  and  anti-p58  (D). 
FITC or  Texas  Red labeled sec- 
ondary reagents were used to 
detect binding of anti-p58 and 
anti-CD antigens, respectively 
(see Fig. 2). An arrowinA and 
B  indicates  possible  tubular 
structures that co-stain for  p58 
and CIM. 
steady-state conditions, these data indicate that the extent to 
which the various chimeras access/dwell in the intermediate 
compartment may be dependent on the sequence context of 
the double lysine motif  and whether the marker protein con- 
sists of a  single chain or a homodimer. 
Redistribution of CD4/E19 to the Golgi Region 
after Warm-up  from a 16°C Incubation 
Incubation of cells at  160C  followed by brief warm-up to 
370C has been shown to result in a dramatic redistribution 
of both p58 and p53  (Schweizer et al.,  1990;  Lippincott- 
Schwartz  et  al.,  1990;  Saraste  and  Svensson,  1991).  At 
16°C,  these molecules concentrate in pre-Golgi structures 
located throughout the cytoplasm. Upon warm-up to 37°C 
they move synchronously into the Golgi region before relo- 
cating back to the ER and returning to steady-state distribu- 
tion intermediate between the ER and Golgi (Schweizer et 
al.,  1990;  Lippincott-Schwartz et al.,  1990;  Saraste  and 
Svensson, 1991).  These data have been interpreted as dem- 
onstrating that marker proteins of the intermediate compart- 
ment are recycling between the ER and the Golgi complex. 
We have carried out temperature shift experiments in order 
to determine if the subeellular distribution of our marker 
proteins tagged with the double-lysine motif  were affected  by 
this treatment (Fig. 3). CIM/E19 was found to colocalize al- 
most entirely with p58 in these experiments, after a brief 
warm-up to 37°C both molecules were observed to concert- 
trate in the Golgi region and in some cells in structures that 
appear more tubular than vesicular in nature (see arrow in 
Fig. 3, A and B) that emanate from this region, p53-positive 
tubular structures have previously  been observed upon warm- 
up from a  16"C incubation, such structures may reflect the 
tubular nature of the retrograde transport (see Hauri and 
Schweizer, 1992; Lippincott-Schwartz et al., 1990). After a 
30 min  warm-up  at  37°C,  CD4/E19  and p58  colocalized 
to more peripheral vesicular structures located throughout 
the cytoplasm (Fig.  3, E  and F).  Similar results were ob- 
served for CD8/E19, however, the level of ER staining was 
always much greater compared to that observed for CD4/ 
El9 (as described above). In contrast, temperature shift ex- 
periments had little affect on the subeellular distribution of 
CD8/I-I25  (Fig. 3, C and D) and there was no noticeable ac- 
emulation of these proteins in structures that costained for 
p58. The finding of these temperature shift experiments are 
fully consistent with a model whereby CD4/E19 and CD8/ 
El9, like p53 and p58, recirculate between the ER and the 
Golgi. 
Disruption of  Microtubules Results in Changes in the 
SubceUular Distribution CD8/EI9 and CD4/EI9 
Morphological evidence has suggested that the return of p58 
and p53 from the intermediate compartment/cis Golgi to the 
ER  (Lippincott-Schwartz et  al.,  1990;  Schweizer et  al., 
1990; Saraste and Svensson, 1991) may be directed by mi- 
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data suggest that the retrograde transport of Golgi proteins 
to the ER in brefeldin A-treated cells is also facilitated by mi- 
crotubules (Lippincott-Sehwartz et al.,  1990). 
Hgure 4. Accumulation of  CD8/E19 and CD4/EI9 
in post ER compartment(s)  in ceils treated with 
nccodazole and/or brefeldin A. 3T3 cells transfeoed 
with expression  plasmids  encoding CD8/E19  (.4 
and B) or CIM/E19 (C-H) were placed at 40C for 
20 rain followed by a 2-h incubation at 37°C in the 
presence of noeodazole. Cells were fixed and per- 
meab'flized as described in Fig. 2 and co-stained 
for CDg/E19 and p58 (,4 and B), CD4/E19 and p58 
(C and D), CD4/E19 and a resident Golgi protein, 
p135, (E and F) and CIM/E19 and a resident ER 
protein, epoxide hydrolase (G and H). The subcel- 
lular distn'bution of CD8/E19 (/and K) and CIM/ 
El9 (J and L) was also determined in transfected 
3"I"3 cells after a 1-h treatment with brefeldin A (I 
and J) or after this treatment followed by a further 
1 1/2-h exposure to nocodazole and brefeldin A (K 
and L). In all cases the El9 chimeras were identi- 
fied using Texas red reagents and the other proteins 
were identified using fluorescein secondary anti- 
bodies. 
Treatment of  cells with nocodazole, a microtubule-disrupt- 
ing drug (De Brabander et al., 1976) resulted in pronounced 
colocalization of both CDS/E19 and CD4/E19 with p58 in 
vesicular structures (Fig. 4) that did not stain with the anti- 
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immunofluorescence  localiza- 
tion of KDEL and El9 pro- 
reins. HeLa cells transfected 
with plasmids encoding CD4/ 
El9 and CDS/KDEL (.4, B, 
and E) or CDS/E19 and pre- 
albumin/KDEL  (C  and  D) 
were fixed and processed for. 
immunofluorescence micros- 
copy either without pretreat- 
ment (,4 and B), or after pre- 
treatment with brefeldin  A and 
nocodazole  (C-E) as described 
in Fig. 4. In each  case, El9 pro- 
teins were detected with Texas 
red reagents and KDEL pro- 
teins with fluorescein second- 
ary antibodies. Fig. 4 E is a 
higher magnification  image of 
the perinuclear region of  a cell 
stained as in Fig. 4, C and D 
obtained by confocal micros- 
copy. 
ER antibodies (Fig. 4, G and H). This treatment also caused 
a significant change in the morphology of the intermediate 
compartment (see Saraste and Svensson,  1991). The orga- 
helle became dispersed throughout the cytoplasm and nu- 
merous, much enlarged vesicles were stained by the anti-p58 
antibody. This staining pattern is very similar to, and par- 
tially overlapping with that observed with an anti-Golgi anti- 
body (Burke et al.,  1982),  mak/ng it difficult to determine 
to what degree the E19 tagged proteins are colocalizing with 
the intermediate compartment or with the Golgi membranes 
after this treatment (see Fig. 4, E  and F) (see Saraste and 
Svensson, 1991). However, the staining pattern in untreated 
cells (Fig. 2) and the finding that some of the CDS/E19 and 
much of the CD4/E19 molecules were localized to the p58- 
staining compartment in brefeldin A-treated cells (Fig. 4 J) 
indicates that in the absence of nocodazole these proteins 
predominantly access the intermediate compartment (Lip- 
pincott-Schwartz et al.,  1990).  Treatment of cells with bre- 
feldin A for 1 h followed by nocodazole for 1 1/2 h resulted 
in an apparent accumulation of CD4/E19 and CD8/E19 into 
vesicular structures scattered throughout the cell (Fig. 3, L 
and g), that costained with p58. However, none of the treat- 
merits promoted colocalization of the CDS/H25, CDS/HP1 
or CD8/53kSER with the p58-staining vesicles. 
Three different marker proteins tagged with the KDEL 
motif, CD8/KDEL, HLA A2/KDEL  and prealbumin/KDEL 
(see exper/mental procedures) were not localized to the inter- 
mediate compartment under any of the conditions described 
above. In untreated cells all three proteins colocalized with 
CD8/E19 in the ER but also occurred in small,  brightly 
stained vesicles near the nucleus which did not stain for 
CDS/E19, CD4/E19, epoxide hydrolase  or UDP-glucuronosyl- 
transferase (Fig. 5, A and B). Nocodazole treatment resulted 
in  a  significant accumulation of the  vesicles  specifically 
stained by the KDEL tagged proteins.  In many instances 
there was a spatial association of  these vesicles and the inter- 
mediate compartment vesicles. This association was more 
pronounced if cells are also treated with brefeldin A. Fig. 5, 
Cand D, show that vesicles staining strongly for CD8/KDEL 
near the periphery of  the cell were clustered around a vesicle 
that stained for CD4/E19, this association was also apparent 
in the peri-nuclear region when high magnification confocal 
microscopy was used (Fig. 5 E). The exact relationship be- 
tween these two sets of vesicles is unclear. However, their 
spatial association raises  the possibility that CDS/KDEL 
may be sorted and concentrated into specialized structures 
before retrieval. 
Depolymerization  of  Microtubules Increases the Rate 
of  GalNAc Addition to CDS/E19 and CDS/KDEL 
If retrieval in normal cells is dependent on microtubules, 
then the  rate  of GalNAc addition to  CDS/E19  might be 
affected by  nocodazole treatment.  Cells  transfected with 
CD8/E19,  CDS/E19-3S,  CD8/H25,  CDSKDEL were pre- 
treated with nocodazole or mock treated and labeled for 3 
min followed by frequent chase time points. Fig. 6 A shows 
that pretreatment of cells with nocodazole increased the per- 
centage of CD8/E19 that acquired GalNAc at early chase 
times, with less of an affect on the additions to CDS/E19-3S 
(compare the 6-rain chase time in the presence and absence 
of  nocodazole for CDS/E19 and CDS/E19-3S). The effect on 
CDS/KDEL  was  more  pronounced  (compare  the  9-rain 
chase time with and without nocodazole). To allow for a 
more  quantitative evaluation of this  information we have 
used a lazer densitometer to determine the relative amounts 
of protein with and without carbohydrate at each time point 
(the carbohydrate free protein species are marked with an 
asterisk and a triangle; see Fig. 1 for details). Fig. 6 B shows 
graphs of the rate at which each of the proteins acquire car- 
bohydrate in the presence and absence of nocodazole. The 
mean values obtained from the data in Fig. 6 A and two simi- 
The Journal  of Cell Biology,  Volume 121, 1993  324 Figure 6.  The rate of GalNAc 
addition  to  CD8/E19  and 
CD8/KDEL increases  in cells 
treated  with  nocodazole.  (A) 
HeLa  ceils  transfected  with 
the expression  plasmids indi- 
cated  in  the  figure  were  la- 
beled  for  3  rain  with  [35S]- 
methionine and subsequently 
chased in the presence of me- 
dium  containing  unlabeled 
methionine for the times indi- 
cated. For each construct, two 
identical  series of pulse/chase 
plates were set up. 2 1/2 h be- 
fore labeling, both series were 
placed in ice cold medium for 
20 rain.  Subsequently,  one set 
of plates  was returned to nor- 
mal medium while the other 
was  placed  in  medium  con- 
taining 10 tLg/ml necodazole. 
Nocodazole  was  maintained 
in  the  prelabeling,  labeling, 
and chase medium. Transport 
was stopped at the chase times 
indicated in the figure by addi- 
tion of lysis buffer (1% Triton 
X-100/PBS). A shows analysis 
of the CD8 proteins immuno- 
precipitated  from the lysates 
and analyzed by SDS PAGE as 
described in Fig. 1. The aster- 
isk and triangle indicate  spe- 
cies of CD8 devoid of carbo- 
hydrate  (see Fig.  1).  (B) The 
autoradiographs in A and two 
similar experiments  were sub- 
jected to densitometry using 
an LKB (Pharmacia LKB Bio- 
technology,  Inc.)  ultrosean. 
The relative  amounts of pro- 
tein  without  (marked  by the 
asterisk and triangle) and with 
carbohydrate  at  each  time 
point were determined.  These 
values allowed us to calculate 
the percent of  protein with car- 
bohydrate at each time point. 
B  shows  mean  values  (from 
three  experiments)  of  these 
percentages,  plotted  against 
the corresponding chase time. 
(Note that these analyses also 
allowed  us to determine that 
the levels of protein recovered 
over the chase period varied 
by <25%). 
lar experiments show that there was a significant increase in 
the rate at which CD8/E19 and CD8/KDEL received carbo- 
hydrate in nocodazole treated compared to untreated cells, 
with a lesser effect on CD8/H25 and even less on CD8/E19- 
3S.  Assuming that  the  various  CD8  chimeras  are  equally 
good substrates for the transferase(s)  (see below for details) 
these data suggest that nocodazole treatment does not simply 
result in a general increase of GalNAc transferase activity in 
the ER.  The observed effects of nocodazole are,  however, 
consistent with the view that an intact microtubular network 
ordinarily  limits  the  exposure  of the  ER-retrieved  CD8 
chimeras to GalNAc transferase. 
Jackson et al. Retrieval of Membrane Proteins to the ER  325 Figure 7. Post-translational modification of CD8 chimeras in cells treated with brefeldin A. HeLa cells transfected with the expression 
plasmids indicated in the figure were labeled for 5 rain with [3SS]methionine  and subsequently chased for the times indicated. Two series 
of pulse/chase plates were set up for each construct. These were treated identically except that brefeldin A (2/~g/ml) was added to one 
series 1 h before labeling and the drug was maintained in the labeling and chase media. The labeled CD8 proteins were collected and 
analyzed as described in Fig. 6. Note that due to its smaller size the various post-translationally modified forms of CD8/KDEL are better 
resolved on the SDS gels than the post-translationally modified forms of the transmembrane CD8 chimeras (see Fig. 1). 
Different, ER-maintained CD8 Chimeras 
Receive GalNAc at Approximately the Same Rate 
in the Presence of  Brefeidin A 
The data shown in Fig. 6 indicated that CD8/H25 acquired 
GalNAc more slowly than CD8/E19. After a chase period of 
8 h (Fig. 7) some of the CDS/H25 (species marked by dots 
in Figs. 7 and 8 A) had still not acquired a full complement 
of GalNAc in contrast to CDS/E19.  A  similar analysis of 
CDS/HP1, CDS/53kSER and CDS/HMG CoA (not shown) 
revealed that CDS/HP1 and CDS/53kSER received GalNAc 
very slowly, like CDS/H25, while CD8/HMGCoA behaved 
like  CD8/E19.  One  interpretation of these  results  is  that 
CD8/E19 and CD8/HMGCoA receive a greater exposure to 
post-ER localized transferase(s), a suggestion that is particu- 
larly attractive  as  it  is  the  predicted  consequence of the 
finding that only these two CD8 chimeras localized to the in- 
termediate compartment (Fig. 2). The alternative explana- 
tion, that the different chimeras are not equally good sub- 
strates for the transferase, reflecting differences in either the 
rates of folding of the proteins or differences in the final con- 
formation of the folded proteins,  seemed less likely for a 
number of reasons. First, the different CD8 chimeras differ 
only in the sequence of the last 10 amino acids of their 15 
residue long cytoplasmic tails.  The sequences of their lu- 
menal and transmembrane domains are identical (see Fig. 2 
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Intermediate  Neuraminadase/ 
compartment  Endo H resistant 
Chimeric  staining  carbohydrate 
protein  (Figs. 3 and 4)  (Fig. 6, A and B) 
Time*  PNA~ 
GalNAc  staining 
+ palmitate  ER 
(Figs. 6 A and 7)  (Fig. 8) 
CD8/EI9  X  X 
CDS/HMG CoA  X  X 
CD8/I-I25  -  - 
CDS/HPI  -  - 
CD8/53kSER  -  - 
CD4/E19  XXX  X 
CIM/HMG CoA  XXX  X 
CIM/H25  x  - 
CD4/HP1  X  - 
CD4/53kSER  X  - 
'~4 h  X 




* These values were obtained from pulse chase analyses (eg., Figs. 6 and 7);  the values shown are an approximation of the chase time required for >95% of 
a given chimera to migrate with a mobility adjacent to the band marked with a square (see Figs. 1, 6, and 7), the form we suggest  has a full complement of GalNAe 
and palmitate. 
The data shown are from experiments described in Fig.  8 and similar analyses of CDS/HMG CoA, CD8/HP1 and CDS/53kSER. 
E). It would be surprising if these differences were transmit- 
ted through the transmembrane portion to alter the folding 
of the lumenal domain of CDS, the portion the transferase 
acts upon (see Nilsson et al., 1989). Secondly, three different 
conformation-sensitive  anti-CD8  monoclonal  antibodies 
reacted equally well with each of the CD8 chimeras and de- 
tected no differences in the time required for each chimera 
to fold into a conformation recognized by the antibodies. 
To examine if each of the CD8 chimeras could be modified 
at approximately the same rate, if they were equally exposed 
to GalNAc transferase we treated cells with brefeldin A for 
1 h before biosynthetic pulse chase experiments. This treat- 
ment has previously been shown to result in the collapse of 
post ER compartments into the ER (Lippincott-Schwartz et 
al., 1989). The most striking affect of this treatment was that 
all the CD8 chimeras now acquired GaiNAc extremely rap- 
idly  (Fig.  7).  Similar  results  were  found  for  CD8/HP1, 
CD8/53kSER and CD8/HMGCoA (not shown). At the end 
of the labeling period little unglycosylated protein was seen 
in contrast to the results of untreated cells. With time, all the 
CD8 chimeras in the treated cells acquired post-translational 
modifications at approximately the same rate, indicating that 
the different proteins were about equally good substrates for 
the transferases. These data suggest that the majority of the 
GalNAc transferase activity in untreated cells is located in 
a post ER compartment(s) and that the differences in the 
rates at which the different CD8 chimeras acquired GalNAc 
might be due to their differential exposure to these post ER 
enzymes. 
Marker Proteins with E19 or KDEL Motifs Receive 
Golgi ModiIications 
After 8 h of chase CD8/E19 had received modifications in 
addition to GalNAc (Fig.  7),  suggesting that the O-linked 
sugars  had been  further modified, perhaps  by  Golgi en- 
zymes. Golgi additions to wild type CD8 have been deter- 
mined to be galactose, GlucNAc and sialic acid (Pascale et 
al.,  1992).  Neuraminadase treatment of CD8/E19 showed 
that after 24 h, a significant proportion of the molecules had 
indeed received sialic acid (Fig. 8 A). In contrast, little if any 
CD8/H25  had  received  sialic  acid.  Similar  results  were 
found for CD8/HP1  and CD8/53kSER.  A parallel experi- 
ment with CD8/KDEL showed that at the end of the chase 
period, ~,50% of the protein had acquired sialic acid (Fig. 
8 A). Moreover, a small amount of  the CD8/KDEL had been 
secreted into the culture medium. The slow stepwise addi- 
tion of carbohydrate to CD8/E19 and CD8/KDEL by en- 
zymes considered to be of Golgi origin (Farquhar,  1985; 
Piller et ai.,  1989) is difficult to explain by leakage past a 
single pre-Golgi point of retention/retrieval. Transport past 
such a point would be expected to result in the rapid addition 
of sialic acid to all carbohydrates followed by expression on 
the  cell  surface or  secretion as  indeed  we  observed for 
CD8/E19-3S and CD8sol,  respectively (Fig.  1, A and C). 
Furthermore, leakage of CD8/E19 is unlikely as we have 
been unable to detect CD8/E19 on the cell surface (Jackson 
et al.,  1990). 
The above data raised the possibility that the N-linked car- 
bohydrates on CIM/E19  (Nilsson  et al.,  1989)  and HLA 
A2.2/E19  (see Materials  and  Methods  for details)  might 
also  be  modified by  Golgi enzymes.  Endoglycosidase H 
(Endo H)  was  used to identify Golgi modification of the 
N-linked sugars, as resistance to this enzyme occurs if the 
carbohydrates have been modified by medial Golgi enzymes 
(Kornfeld and Kornfeld, 1985). Fig. 8 B shows that after a 
16-h chase period a small portion of the N-linked sugars on 
CD4/E19  and  '~20%  of  the  N-linked  carbohydrate  on 
A2.2/E19 were found to be resistant to Endo H  (indicated 
by an arrow in Fig. 8 B). Interestingly, the N-linked sugars 
on CIM/H25 or CD4/HP1 did not become endo H resistant 
even after a chase period of 24 h, results entirely analogous 
to those obtained with the CD8 chimeras (see Table I). Thus, 
using  two  different marker  proteins  and  unrelated  Golgi 
modifications we show that the degree of exposure to Golgi 
proteins of a given chimera is dictated by the sequence con- 
text of the double lysine motif. We conclude from these data 
that marker proteins maintained in the ER by either a double 
lysine or KDEL motif  are slowly exposed to enzymes recog- 
nized as Golgi residents. 
Retrieval of Golgi Modified CD8/EI9 and CD8/KDEL 
to the ER 
Taken together the results described above and summarized 
in Table I, provide good evidence that proteins accumulated 
Jackson et al. Retrieval of Membrane Proteins  to the ER  327 Figure  8. O- and N-linked sugars  on -El9 and -KDEL tagged  proteins receive Golgi modifications.  HeLa  ceils transfected  with an expression 
plasmid encoding the protein indicated in the figure were labeled for 1 h with [35S]methionine  and then chased in the presence of medium 
containing  unlabeled methionine  for the times indicated  before  lysis of  the cells with Triton X-100. (A) CD8 protein was immunoprecipitated 
from the ceil lysates and also from the 24-h chase medium of CDS/KDEL. Before analysis  by SDS PAGE, half of each sample was treated 
with neuraminadase. (B) CD4/E19 and A2.2/E19 were immunoprecipitated  from the cell lysates using mAbs 19Thy/5D7  and BB7.2, respec- 
tively. Before SDS PAGE  analysis, half  of each sample was treated overnight  with endoglycosidase  H. Overexposure  of the gel was required 
to see the endo H resistant forms of the protein which are indicated with an arrow in the figure. 
in the ER as a result of a double lysine or a KDEL motif  have 
access to post-ER compartments. However they do not prove 
that these escaped proteins modified  by post-ER enzymes are 
subsequently retrieved to the ER. To investigate this, we ana- 
lyzed whether the ER of cells expressing high levels of these 
CD8 chimeras could be stained with lectins (see Roth, 1984; 
Piller et al., 1989;  1990) which recognize specific terminal 
glycans. Helix pomatia (HPA) and Arachis hypogaea (PNA) 
lectins were used to stain for terminal GalNAc and terminal 
Gal(1-3)GalNAc,  respectively  (Hammarstrom  and  Kabat, 
1969).  It is important to note that binding of the lectin re- 
quires the glycan to occupy a terminal position.  Thus, if 
galactose is added to GalNAc it is not recognized well by 
HPA. Similarly if sialic acid is added to Gai-GalNAc, reac- 
tivity to PNA is virtually eliminated (Piller et al.,  1989). 
HeLa ceils transiently transfected with plasmid DNA encod- 
ing various CD8 chimeras (see Table I) were stained with 
HPA and PNA lectins. Fig. 9 shows that in cells expressing 
high levels of each of these CD8  chimeras (identified by 
staining with anti-CD8 antibodies) the cells stain strongly 
with HPA (Fig. 9, B and D, see Table I). The staining pattern 
by HPA in transfected cells colocalized with that for the CD8 
chimeras  and  also  with the  ER  marker  protein  epoxide 
hydrolase indicating that the lectin is staining the ER. Fur- 
thermore staining by HPA of the characteristic membrane 
network  of  the ER was clearly visible at the periphery of  ceils, 
see Fig. 9, B and D. In the adjacent untransfected cells (not 
stained by anti-CD8 antibodies, Fig. 9, A and C), HPA lectin 
primarily stained the Golgi region of cells, see arrow in Fig. 
9, B and D, the expected location for endogenous proteins 
with only partially processed carbohydrate, whereas the ER 
stained very weakly (see Discussion). Similar results were 
found for CD8/E19, CD8/HMGCoA and CD8/KDEL when 
cells were stained with PNA lectin (Fig. 9, E-H), in untrans- 
fected cells only the Golgi stained (arrows,  Fig. 9, F and H) 
whereas in transfected cells the ER stained strongly with the 
PNA. However when we analyzed the other CDS/chimeras 
(see Table I), we found that even in cells expressing high lev- 
els of CDS/H25, CDS/HPI or CDS/53kSER the ER did not 
stain with PNA. These observations complement the pulse 
chase  data  which  showed  significant Golgi  additions  to 
CDS/E19,  CDS/HMG CoA and CDS/KDEL, but not to the 
other ER maintained CD8 chimeras after 24 h of chase (see 
Table I). 
Further evidence that Golgi modified CD8/E19 were lo- 
cated in the ER was obtained by subcelhilar fractionation on 
sucrose density gradients  (Bole et al.,  1986;  Hsu et al., 
1991).  CD8/E19  modified by  the  addition of sialic  acid 
(identified by neuraminadase treatment, see Fig. 8 A) was 
found to be primarily localized to the more dense membrane 
fractions, previously defined as the rough and smooth ER 
(Bole et al., 1986),  with only low levels in the lighter mem- 
brane  fractions  marked  by  the  Golgi  enzyme,  galac- 
tosyltransferase (Fig. 10). Sialylated CDS/E19 and a smooth 
ER marker protein, epoxide hydrolase were found to be dis- 
tributed in a quantitatively similar manner over the gradient, 
(compare  Fig.  10,  B  and  C).  Furthermore,  sialylated 
CD8/E19 had an almost identical distribution over the gra- 
dient as  CDS/E19  modified by addition of only GalNAc 
(compare Fig. I0, C and D). Taken together, the results from 
these  lectin binding and  subcellular  fractionation experi- 
ments provides strong evidence that proteins maintained in 
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the ER from post ER compartments. A conclusion strongly 
supported  by  our  observation that  marker protein  tagged 
with the El9 motif redistribute initially to the Golgi region 
and subsequently back to the ER/intermediate compartment 
upon warming of cells to 37°C after a 2-h incubation at 16°C 
(Fig.  3). 
Discussion 
Double-Lysine Tagged Proteins are Modified 
in PostER Compartment(s) 
To determine whether the double-lysine motif serves as a re- 
Figure 9. Immunofluorescence 
localization of Golgi modified 
CD8 proteins to the ER by lec- 
tin staining.  HeLa cells tran- 
siently transfec~ with expres- 
sion plasmids encoding CD8/ 
I-I25 (.4 and B), CD8/KDEL 
(C, D, G and H) or CD8/E19 
(E-F) were fixed and perme- 
abilized as in Fig. 2 followed 
by incubation with Helix po- 
maria (HPA) lectin  (A-D) or 
Arachis hypogaea (PNA) lec- 
tin  (E-H).  Rabbit  antileetin 
antisera and mouse anti-CD8 
antibody, OKTS, were used in 
conjunction  with  fluorescein 
anti-rabbit and Texas red anti- 
mouse secondary reagents to 
detect, lectin binding and CDS, 
respectively. To reduce bind- 
ing of PNA to the cell surface 
ceils  (E-H)  were  incubated 
with  Bauhinia purpurea ag- 
glutinin (BPA) for 20 min be- 
fore fixation, permeabilization 
and PNA staining.  Note that 
as transiently transfected ceils 
were  used  for these  experi- 
ments both transfeOed (stained 
by anti-CD8  antibodies)  and 
nontransfected ceils are shown 
in each panel.  Golgi staining 
of untransfected  ceils  by the 
lectins is indicated by arrows 
in the figure. 
trieval rather than as a retention signal, we analyzed the post- 
translational  modifications  of  CD8/E19.  Conclusive  evi- 
dence is provided that this protein rapidly receives GalNAc 
and palmitate, modifications reported to occur in post ER lo- 
cation(s). However these reports (Bonatti et al., 1989; Tooze 
et al.,  1988) could not rule out low levels of activity in the 
ER. Indeed herein lies one of  the fundamental problems with 
using post-translational modifications to map the intracellu- 
lar trafficking of proteins. This problem is particularly acute 
in the secretory pathway as the various modifying enzymes 
and the protein in question are first synthesized into the ER. 
Furthermore,  although  recent data  suggest Golgi proteins 
are most likely targeted by aggregation (Nilsson et al., 1991) 
we cannot rule out that their location may be determined by 
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Figure 10. Sialylated CD8/E19  co-localizes  with ER marker pro- 
teins upon subeellular fractionation. HeLa cells expressing CD8/ 
El9 were metabolically labeled with [35S]methionine for 4 h fol- 
lowed by a 24-h chase period in the presence of unlabeled methio- 
nine. Subcellnlar fractionation of homogenates  of these labeled 
cells was carried out on discontinuous sucrose  gradients as de- 
scribed by Bole et al., 1986 (see Hsu et al., 1991). A shows the dis- 
tribution of the Golgi marker, galactosyltransferase  over the gradi- 
ent, as measured by the CPM of radiolabeled galactose transferred 
to ovalbumin  (Bole et al., 1986). The distribution  of epoxide hydro- 
lase (B) and CD8/E19 (C and D) over the gradient was determined 
by immunoprecipitation  followed by SDS PAGE and quantitation 
of the amount of radioactivity (CPM) in specific bands using an 
Ambis radioanalytic  imager. C and D show the distribution  over the 
gradient of sialylated CDS/EI9 (i.e., the neuraminadase sensitive 
forms,  Fig.  8  A)  and  GalNAc modified  CD8/E19,  (Fig.  8  A, 
square),  respectively. 
the balance of retrograde targeting and anterograde bulk 
flow. 
I  To control these problems, we have analyzed the rates of 
post-translational modification of a series of CD8 chimeras, 
all maintained in the ER, but by double-lysine motifs from 
different ER resident proteins. We show that these chimeras 
receive  O-linked carbohydrate at  quite  different rates,  a 
finding that is difficult to explain by low levels of ER located 
transferase.  We suggest that these rate differences reflect 
differences in the strength of the various retrieval signals, 
whereby the strength of the motif dictates the dwell time in, 
and thus, exposure to, post ER locations. This suggestion is 
supported by the subcellular distribution of  the different  CD8 
and CIM chimeras (see Table I) and is an obvious extension 
of our previous findings, that the transport rates of CD8 
chimeras is directly related to the sequence context and posi- 
tion of  the double-lysine motif  (Nilsson et al., 1989; Jackson 
et al., 1990). We have not found evidence to support the al- 
ternative interpretation, i.e., that the different chimeras are 
not equally good  substrates  for ER located transferases. 
Conformational-specific anti-CD8 antibodies did not detect 
any difference in either the rate at which the various chimeras 
fold or their final folded state. Further, we showed that the 
various chimeras received GalNAc with very similar rates in 
brefeldin A treated cells, indicating that they are more or less 
equally good as substrates for the transferases. Perhaps the 
most convincing argument that the sequence of cytoplasmic 
tail effect the retrieval process, rather than a conformation 
of  the marker protein, is that transferring the same set of  cyto- 
plasmic tails from CD8 to a different marker protein, CD4, 
also transfers the rank order in both the rates at which the 
carbohydrates on this marker protein are modified by post- 
ER enzymes and the degree to which each chimera colocal- 
izes with the p58 marker protein (Table I). 
Thus, the most plausible explanation for the types and rates 
of post-translational modifications of CD8/E19 observed is 
that these are received primarily outside the ER. This sug- 
gestion is supported by the observation that CD8/E19 and 
CD8/KDEL (a protein maintained in the ER by retrieval from 
post ER compartments [Pelham, 1988, 1989]) receive these 
modifications at about the same rate (Figs.  6 and 8). 
Retrieval Versus Retention 
The best evidence that the double-lysine motif  directs the re- 
trieval of these post-translationatly modified proteins back tO 
the ER is provided by the lectin staining. We show that the 
ER of cells expressing high levels of CD8/E19 stained with 
PNA (Fig. 9 F), a lectin that specifically recognizes the char- 
acterisfic Golgi addition of galactose. Most interesting was 
the relative lack of  ER staining by both HPA and PNA in un- 
transfected cells (Fig. 9, A, C, and E), indicating that few 
ER resident proteins are modified by addition of GalNAc or 
galactose. This finding indicates that either the majority of 
ER resident proteins are not substrates for O-glycosylation 
or,  that  in  contrast  to  our  tagged  marker  proteins,  the 
majority of ER resident proteins are not continuously recir- 
culating between the ER and post-ER compartments. The 
latter suggestion is consistent with reports that in contrast 
to CIM/E19,  endogenous ER resident proteins lack Endo 
H-resistant carbohydrate moieties (Kornfeld and Kornfeld, 
1985). Moreover, removal of  the ER targeting motif  from ER 
proteins such as UDPGT HP1  (M.  Jackson, unpublished 
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(Mazzarella et al., 1990) results in slow if any transport of 
the truncated molecules. These and other observations (see 
Hurtley and Helenius, 1989; Rose and Doms, 1988) indicate 
that many ER proteins never leave this organelle. How such 
proteins are retained in the ER remains enigmatic, but vari- 
ous models have been proposed (Hortsch and Meyer, 1985; 
Booth and Koch,  1989; Suzuki et al.,  1991). In terms  of 
efficiency, it would make much sense if the majority of the 
ER proteins were prevented from leaving the ER. A combi- 
nation of retention and retrieval would ensure minimal leak- 
age, and would explain why marker proteins with a KDEL 
motif, eg.,  CD8/KDEL (see  Zagouras  and Rose,  1989), 
which rely on retrieval only, are very slowly secreted while 
endogenous ER soluble -KDEL proteins (Booth and Koch, 
1989) are fully retained in the cell. This would imply that 
the double-lysine motif  and the KDEL sequence are salvage 
sequences (Warren,  1987) and they should accordingly be 
referred to as retrieval motifs. 
The SubceUular Distribution of  Marlwr Proteins 
Depends on the Sequence Context of the Retrieval 
Motif  and Intact Microtubules 
The immunofluorescence data colocalizing  CD4/E19  and 
CD8/E19 with the p58 antigen is the first demonstration that 
protein tagged with a retrieval motif is present in the inter- 
mediate compartment.  The finding that these two proteins, 
like the marker proteins  of the intermediate  compartment 
p58 and p53, accumulate initially in the Golgi region and 
subsequently redistribute to more peripheral ER locations in 
the cell upon warm-up from 160C (Fig. 3) supports a model 
(Hauri and Schweizer, 1992) in which these proteins are con- 
tinually recirculating between the ER and the Golgi. These 
experiments  also  confirm  that  the  El9  tagged  proteins 
colocalizing  with p58  are localized to post-ER  structures 
rather than to specialized exit sites from the ER as although 
significant overlap occurs in the staining pattern for p53 and 
p63  (p63 is recognized as a marker protein  for these exit 
sites), the distribution of  p63 is unaffected by such tempera- 
ture shift experiments (Hauri and Schweizer, 1992). 
Not all of the CD8 chimeras could be clearly visualized 
in the intermediate  compartment,  for example CD8/H25, 
CDS/HP1, CD8/53kSER and CD8/KDEL, like the endoge- 
nous ER resident proteins BiP, PDI (Schweizer et al., 1990, 
1991) and UDPGTs (M. Jackson, unpublished data) were not 
noticeably accumulated in p58 staining vesicular structures. 
Because morphological  analyses reflect steady-state distri- 
butions of proteins, it is possible that our inability to detect 
these proteins in post-ER structures reflects the fact that they 
are very rapidly retrieved and thus never accumulate in post- 
ER locations to a level sufficiently high to be detected. This 
assumption predicts that one and two copies, of a retrieval 
motif  on a molecule would confer different subcellular distri- 
butions. The observation that CD4/E19 and HLA A2.2/E19 
(data not shown), which are monomers, strongly coloealized 
with the p58 antigen while CD8/E19, a homodimer, with an 
otherwise identical cytoplasmic tail sequence, weakly local- 
izes to the p58 antigen compartment is consistent with this 
notion. A retrieval process whose efficiency is dependent on 
the context of  the double-lysine motif  would also explain our 
previous observation that the exit rate of CD8/E19 mutants 
was found to be more or less directly proportional  to the 
length  of the  truncation/addition  to the carboxyterminus 
(Nilsson et al.,  1989; Jackson et al.,  1990). 
The recent finding that the carboxy-terminal sequence of 
the intermediate compartment marker protein p53 contains 
lysine residues located 3 and 4 residues from the carboxy ter- 
minus of  the protein (Hauri and Schweizer, 1992) lends fur- 
ther support to our contention that the double lysine motif 
is a retrieval rather than a retention signal. It also suggests 
that the  localization of  a protein to the intermediate compart- 
ment may simply reflect the steady-state distribution  of a 
protein  continually  recycling between  the ER  and Golgi 
complex. If  the balance of  anterograde and retrograde trans- 
port were to be altered then one would predict a change in 
the steady-state distribution of  the recirculating proteins (see 
Hauri and Schweizer, 1992). At 16°C, the delivery of pro- 
teins to the Golgi complex is recognized as being blocked 
however exit out of the ER is not. Reduced temperature has 
thereby upset the normal balance of anterograde and retro- 
grade transport.  The synchronized redistribution  of mole- 
cules upon warm-up has been interpreted as the result of a 
wave of molecules being delivered to the Golgi with subse- 
quent retrieval of  p58 and El9 tagged proteins to the ER and 
with time relocation of these proteins back to their original 
steady-state distribution before perturbation.  Similarly, the 
apparent  increase  in  the  concentration  of CD8/E19  and 
CD4/E19 in the intermediate compartment  in nocodazole- 
treated cells may be the result of  this drug reducing the retro- 
grade  relative to the anterograde  transport.  A  suggestion 
supported by the observed alterations in the kinetics of post- 
translational  modification of CD8/E19  in the presence  of 
nocodazole (Fig. 6) and one that is consistent with the previ- 
ous data that depolymerization of  microtubules affects retro- 
grade delivery of Golgi proteins to the ER in the presence 
of brefeldin A (Lippincott-Schwartz et al., 1990). However, 
nocodazole treatment did not result in an obvious accumula- 
tion of CD8/H25 in intermediate compartment (Fig. 3, Cand 
D)  nor did  it affect the kinetics  of GalNAe  addition  to 
CDS/H25 to the same extent as to CDS/E19 (Fig. 6 B). We 
suggest that if microtubules are utilized in retrograde trans- 
port their role is to facilitate more long distance  retrieval 
operations.  Thus,  it is possible that the more efficiently a 
protein  is retrieved,  the less dependent  this process  is on 
microtubules. The anterograde transport also seemed to be 
affected  by  microtubules  because  CD8/E19-3S acquired 
sialic acid more slowly in nocodazole-treated cells (Fig. 6 
A). Thus, the disorganization of  the Golgi and the intermedi- 
ate compartment in nocodazole-treated cells may result in re- 
duced rates both of antero- and retrograde transport,  but it 
is obvious that neither process is obligatorily dependent on 
an intact microtubule network. 
ER Retrieval Does Not Occur  from 
a Distinct Compartment 
The occurrence  of O-linked  sialic  acid  on CD8/E19  and 
CD8/KDEL, and the existence of endo H-resistant forms of 
CD4/E19 and HLA A2.2/E19 suggest that these proteins had 
access to the cis and probably also medial Golgi compart- 
ments (Kornfeld and Kornfeld, 1985; Farquhar, 1985). How- 
ever, simply altering the sequence context of the ER target- 
ring motif  on CD8/E19 or CD4/E19, resulted in proteins that 
were still accumulated in the ER but which received little or 
no modifications by Golgi enzymes (Fig. 8). These data in 
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the CD8 chimeras (see Table I) raise the possibility that the 
various chimeras are retrieved to the ER with different  ki- 
netics. Assuming that the forward rates of transport of these 
proteins are identical, (which is quite possible given that the 
chimeras differ only in their tail sequences) then one might 
expect on average,  that  retrieval  of the different  chimeras 
would occur from different sites in the exocytotic pathway; 
a view supported by differences in subcellular distribution of 
the various CD8 and CD4 chimeras (Table D. We envisage 
(see below) that retrieval of proteins to the ER as a continu- 
ous process, sorting occurring as soon as the proteins exit 
the ER and continuing from through out the secretory path- 
way. By altering the strength (context) or number of retrieval 
signals the steady state distribution  of a protein may be al- 
tered from almost exclusively ER, eg., CD8/H25 to almost 
entirely post-ER eg. p53. 
Small  but  significant  amounts  of  CD8/KDEL  were 
secreted from the cells. A likely explanation for this observa- 
tion is that CD8/KDEL is recognized by at least one recep- 
tor, which resides in the Golgi (Lewis and Pelham,  1992). 
CD8/KDEL  molecules that succeed in penetrating  further 
along the exocytotic pathway than the receptor distribution 
would thus be secreted. In contrast, proteins containing the 
double-lysine motif have never been detected on the cell sur- 
face (Jackson  et al.,  1990).  This would be fully consistent 
with a stochastic retrieval  process where the double-lysine 
motif is recognized by cytosolic factors, which are not com- 
partmentalized. 
In conclusion, this study  demonstrates that type I trans- 
membrane proteins with the double-lysine motif may exit the 
ER to be retrieved from subsequent compartments  in the 
secretory  pathway. As predicted by Rothman  (1981)  more 
than  10 years ago,  retrieval  of proteins might occur from 
multiple compartments in the exocytotic pathway to increase 
the efficiency of the sorting process. Indeed, the present data 
fully supports  that model. 
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